Skip to main content

Table 3 Results of surgical procedures

From: Long term evaluation of a multidisciplinary trigeminal neuralgia service

 

MVD (%)

SRS (%)

GLYC (%)

RFT (%)

p

n

93

15

28

17

 

No of MDT (%)

    

0.445

1

84 (90.3)

11 (73.3)

22 (78.6)

14 (82.4)

 

2+

9 (9.7)

4 (26.7)

6 (21.4)

3 (17.6)

 

Drug at first visit (%)

    

0.513

 Monotherapy

47 (50.5)

9 (60.0)

13 (46.4)

6 (35.3)

 

 No drugs

9 (9.7)

3 (20.0)

2 (7.1)

2 (11.8)

 

 Polytherapy

37 (39.8)

3 (20.0)

13 (46.4)

9 (52.9)

 

Length of follow up in years (mean (SD))

2.53 (2.60)

4.09 (2.51)

4.14 (2.69)

3.16 (2.41)

0.017

Number reporting any complication

42 (45)

3 (20)

11 (39)

16 (94)

 

Pain (%)

    

<0.001

 Pain free off drugs

64 (71.9)

2 (14.3)

10 (38.5)

8 (50.0)

 

 Pain free on drugs

8 (9.0)

5 (35.7)

7 (26.9)

0 (0.0)

 

 Mild pain

6 (6.7)

2 (14.3)

5 (19.2)

3 (18.8)

 

 Moderate pain

6 (6.7)

3 (21.4)

1 (3.8)

1 (6.2)

 

 Severe pain

5 (5.6)

2 (14.3)

3 (11.5)

4 (25.0)

 

Diagnosis= TN (%)

82 (88.2)

13 (86.7)

27 (96.4)

17 (100.0)

0.275

MS (%)

0 (0.0)

1 (6.7)

3 (10.7)

3 (17.6)

0.003

MDT to surgery in years (mean (SD)

0.67 (1.21)

2.03 (2.68)

1.37 (1.76)

1.04 (2.30)

0.014

Repeat surgery same

5

0

2

5

 

Repeat surgery other

7

5

7

0

 
  1. MVD Microvascular decompression, SRS Stereotactic radiosurgery, GLYC Glycerol rhizotomy, RFT Radiofrequency thermocoagulation, TN Trigeminal neuralgia, MS Multiple sclerosis